Similar articles for PMID: 31990350

Year	Number of Results
1923	1
1933	1
1980	1
1998	1
2000	1
2001	1
2002	2
2003	2
2004	2
2005	6
2006	3
2007	1
2008	3
2009	5
2010	4
2011	5
2012	7
2013	3
2014	12
2015	12
2016	7
2017	9
2018	5
2019	4
2020	8
2021	8
2022	2
2023	3
2024	0

1

Neonatal BCG Vaccination Reduces Interferon-γ Responsiveness to Heterologous Pathogens in Infants From a Randomized Controlled Trial.

Freyne B, Messina NL, Donath S, Germano S, Bonnici R, Gardiner K, Casalaz D, Robins-Browne RM, Netea MG, Flanagan KL, Kollmann T, Curtis N; Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR) Group. Freyne B, et al. J Infect Dis. 2020 Jun 11;221(12):1999-2009. doi: 10.1093/infdis/jiaa030. J Infect Dis. 2020. PMID: 31990350 Free PMC article. Clinical Trial.

2

Neonatal BCG Vaccination Influences Cytokine Responses to Toll-like Receptor Ligands and Heterologous Antigens.

Freyne B, Donath S, Germano S, Gardiner K, Casalaz D, Robins-Browne RM, Amenyogbe N, Messina NL, Netea MG, Flanagan KL, Kollmann T, Curtis N. Freyne B, et al. J Infect Dis. 2018 May 5;217(11):1798-1808. doi: 10.1093/infdis/jiy069. J Infect Dis. 2018. PMID: 29415180 Clinical Trial.

3

Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.

Jensen KJ, Larsen N, Biering-Sørensen S, Andersen A, Eriksen HB, Monteiro I, Hougaard D, Aaby P, Netea MG, Flanagan KL, Benn CS. Jensen KJ, et al. J Infect Dis. 2015 Mar 15;211(6):956-67. doi: 10.1093/infdis/jiu508. Epub 2014 Sep 9. J Infect Dis. 2015. PMID: 25210141 Free PMC article. Clinical Trial.

4

Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.

Nankabirwa V, Tumwine JK, Namugga O, Tylleskär T, Ndeezi G, Robberstad B, Netea MG, Sommerfelt H. Nankabirwa V, et al. Trials. 2017 Mar 31;18(1):152. doi: 10.1186/s13063-017-1881-z. Trials. 2017. PMID: 28359325 Free PMC article. Clinical Trial.

5

Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.

Kiravu A, Osawe S, Happel AU, Nundalall T, Wendoh J, Beer S, Dontsa N, Alinde OB, Mohammed S, Datong P, Cameron DW, Rosenthal K, Abimiku A, Jaspan HB, Gray CM. Kiravu A, et al. Front Immunol. 2019 Oct 1;10:2307. doi: 10.3389/fimmu.2019.02307. eCollection 2019. Front Immunol. 2019. PMID: 31649662 Free PMC article.

6

Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.

Finan C, Ota MO, Marchant A, Newport MJ. Finan C, et al. PLoS One. 2008;3(10):e3485. doi: 10.1371/journal.pone.0003485. Epub 2008 Oct 22. PLoS One. 2008. PMID: 18941532 Free PMC article. Clinical Trial.

7

Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.

Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, van Loenhout J, Xavier RJ, Aaby P, van der Meer JW, van Crevel R, Netea MG. Kleinnijenhuis J, et al. J Innate Immun. 2014;6(2):152-8. doi: 10.1159/000355628. Epub 2013 Oct 30. J Innate Immun. 2014. PMID: 24192057 Free PMC article. Clinical Trial.

8

Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.

Pittet LF, Cox L, Freyne B, Germano S, Bonnici R, Gardiner K, Donath S, Collins CL, Casalaz D, Robins-Browne R, Flanagan KL, Messina NL, Curtis N. Pittet LF, et al. Vaccine. 2022 Feb 23;40(9):1334-1341. doi: 10.1016/j.vaccine.2022.01.005. Epub 2022 Jan 31. Vaccine. 2022. PMID: 35105495 Clinical Trial.

9

Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.

Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, Whittle H, McShane H, Rowland-Jones SL, Flanagan KL. Burl S, et al. J Immunol. 2010 Aug 15;185(4):2620-8. doi: 10.4049/jimmunol.1000552. Epub 2010 Jul 19. J Immunol. 2010. PMID: 20644160 Clinical Trial.

10

Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis.

Mawa PA, Hasso-Agopsowicz M, Lubyayi L, Nabakooza G, Nakibuule M, Blitz R, Dun L, Govind A, Kaleebu P, Webb EL, Elliott AM, Dockrell HM, Cose S, Smith SG. Mawa PA, et al. Front Immunol. 2021 Mar 19;12:637114. doi: 10.3389/fimmu.2021.637114. eCollection 2021. Front Immunol. 2021. PMID: 33815390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year